Who are Precigen, Inc.'s main suppliers?

Precigen, Inc. (PGEN) key suppliers include: Cellectis S.A., Cellectis S.A.. View the full supplier network at chainsifter.com/chain/PGEN.

Who are Precigen, Inc.'s major customers?

Precigen, Inc. (PGEN) key customers include: EXEMPLAR, PRGN-3007-PRECIGEN-ACTOBIO-INC. View the full customer network at chainsifter.com/chain/PGEN.

What sector is Precigen, Inc. in?

Precigen, Inc. (PGEN) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Precigen, Inc. (PGEN) Suppliers & Customers

2Suppliers

2Customers

3Debt Items

12Related Chains

Source-Backed Evidence Depth

Precigen, Inc. (PGEN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships

2Distinct source URLs

5High confidence

0.823Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Precigen, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CLLS	Cellectis S.A.	72%	Reciprocal relationship from CLLS graph: Reciprocal relationship from PGEN graph: Reciprocal relationship from CLLS graph: Reciprocal relationship from PGEN graph: Reciprocal relationship from CLLS g…
CLLS	Cellectis S.A.	72%	ions will be subject to FCPA, which prohibits, among other things, United States companies and their employees and agents from authorizing, promising, offering, or providing, directly or indirectly, …

Precigen, Inc. Customers

Ticker	Name	Confidence	Evidence
EXEMPLAR	EXEMPLAR	92%	Service revenues, which were all generated by Exemplar.
PRGN-3007-PRECIGEN-ACTOBIO-INC	PRGN-3007-PRECIGEN-ACTOBIO-INC	62%	, which considers the internal organization and reporting used by the Company’s chief operating decision maker ("CODM") to make decisions about allocating resources and assessing the Company’s perfor…

Precigen, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
PGEN-DEBT-11754	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
PGEN-DEBT	Debt stack $137.1M	90%	Market cache reports total debt of $137.1M.
PGEN-DEBT-11753	Warrants outstanding: 190060000	90%	xbrl warrant detail from xbrl 2025-12-31.

Precigen, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Precigen, Inc..

Precigen, Inc. Ownership

Holder	Name	Confidence	Evidence
PGEN-OWNER-PATIENT-CAPITAL-MANAGEMENT-LLC	Patient Capital Management, LLC	90%	13F overlay lists Patient Capital Management, LLC as top holder; 205 tracked holders.

Precigen, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
CLLS	Cellectis S.A.	100.00	1	['supplier']
DTIL	Precision BioSciences, Inc.	50.00	2
AZN	AstraZeneca PLC	50.00	2
ALLO	Allogene Therapeutics, Inc.	50.00	2
BMY	Bristol-Myers Squibb Company	50.00	2
BMYMP	Bristol-Myers Squibb Co	50.00	2
TKPHF	Takeda Pharmaceutical Company Limited	50.00	2
TMO	Thermo Fisher Scientific Inc.	50.00	2
IOVA	Iovance Biotherapeutics, Inc.	50.00	2
LYEL	Lyell Immunopharma, Inc.	50.00	2
AUTL	Autolus Therapeutics plc	50.00	2
NTLA	Intellia Therapeutics, Inc.	50.00	2

Precigen, Inc. Supply Chain